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U
nderstanding enzymatic transition states is a powerful tool in bio-
chemistry, especially in the context of designing transition-state 
analogues to act as inhibitors of undesirable or pathological bio-
chemical reactions. Despite the common misrepresentation of a 
protein crystal structure as a static molecule, proteins are highly dynamic, 
as are enzymatic transition states. Even mutations that occur far away from 
enzymatic catalytic sites have the power to change the overall vibrational 
structure of a protein and, by extension, change the nature of its transition 
state. The rationale for wanting to understand enzymatic transition states 
lies in the possibility of designing extremely effective and specific inhibitors. 
The “thermodynamic box” (concep-
tualized by Wolfenden) provides a 
way for thinking about the energies 
of transition states. We know from 
chemical studies that the rates of 
reactions without catalysts are very 
slow. Additionally, scientists can 
measure the rates of enzyme cataly-
sis (turnover) as well as Michaelis 
constants/dissociation constants, 
which give us information about 
how tightly substrate molecules 
bind to enzymes. If, in theory, all 
four sides of the “box” are con-
nected in thermodynamic equilib-
rium, the product of any two sides 
of the square is equal to the product 
of the other two sides. Therefore, 
one can solve for the dissociation 
constant (Kd) of the transition state 
(TS). This tells us how much energy 
it takes at the instant of the TS to 
pull out the transition-state species 
and put it back in. Energetic calcu-
lations show that TS analogues can 
bind 1010 to 1015 times tighter than 
the substrate. These are huge ener-
gies, especially because substrates 
already bind with micromolar dis-
sociation constants. These energies 
essentially represent the irreversibil-
ity of binding. Therefore, scientists 
have set out to make TS analogues 
that should capture part of the bind-
ing energy. In theory, when a per-
fect TS analogue inhibitor binds an 
enzyme, the same enzymatic confor-
mational changes occur as when the 
substrate binds, but all the energy of 
activation is converted into energy 
of binding, represented graphically 
in figure 1 by falling into a stable 
TS energy well (bolded dot). Since 
these TS analogues can bind 1010 
to 1015 times tighter than the sub-
strate, they would make exception-
ally potent inhibitors. 
Understanding enzymatic transi-
tions states is no easy task. Kinetic 
isotope effects (KIE) have been an 
extraordinary resource in helping 
us comprehend the nature of tran-
sition states. Generally, KIE report 
on bond vibrations at the instant 
of catalysis, or the instant when a 
bond is being broken. (Binding iso-
tope effects are different from KIE in 
that they report on the difference in 
bond vibration between two stable 
states.) When an enzyme catalyzes 
a reaction, there are various steps 
involved: binding of the substrate, 
distortion of the substrate, motions, 
TS barrier, and release of products. 
KIE help elucidate what happens at 
the instant of the TS by reporting if 
bond-breaking is a rate-limiting step 
of the process.
First, a target enzyme is selected and 
its substrate is synthesized with iso-
topically labeled atoms. By measur-
ing the isotope effect, a pattern is 
obtained that reports on the bond 
vibrational environment of every 
atom at the instant of the TS. For 
example, if it is determined that 
the carbon-14 at a certain position 
reports a number of 1.026 in measur-
ing the KIE, this means that the iso-
topic substitution slows the reaction 
rate by 2.6 percent. The reported 
number of 1.026 is the ratio of 
the reaction rate of a normal sub-
strate divided by the reaction rate 
of the labeled substrate. The ratios 
reported for each atom tell us about 
what bond vibrational environment 
each atom has at the instant of the 
TS. This is the significance of the KIE.
Now that the various ratios that pro-
vide information about how every 
atom is vibrating at the instant of 
the TS have been obtained, we 
need to back up and figure out 
what kind of TS gives rise to those 
isotope effects. When the molecular 
structures are entered into a com-
puter, software programs can pre-
dict where the TS is by calculating 
the probability of every electron at 
every possible point in space. The 
resulting structure is indicative of 
the most probable transition state 
a reaction will have. What kind of 
isotope effect would that TS give 
us? One can calculate backward and 
get a family of isotope effects. Next, 
one would compare those calculated 
isotope effects (IE) to the experi-
mental IE from the actual TS of the 
enzyme. By comparing experimen-
tal and electronic results, scientists 
can make changes until they find a 
match between the computer-driven 
TS and the actual TS measured in the 
lab. From there, a geometric model 
can be built around two parameters: 
geometry and electrostatics of the 
TS. The model will tell us what we 
need to know about the instant of 
the TS: the geometry, electron dis-
tribution, Van der Waals surface, 
charge interaction, hydrophobic 
forces, hydrogen bonding, and so on. 
By using this model as a blueprint, 
scientists can design a chemically 
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stable molecule that looks like the 
TS, which can act as a potent inhibi-
tor. Therefore, by measuring the KIE, 
and hence the vibrational environ-
ment, of each atom at the instant 
of the TS, investigators are able to 
build models of highly-probable 
transition states that can be used for 
subsequent testing for TS analogue 
inhibitor designs.
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